Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 366

1.

Auto-immune hypoparathyroidism.

Weetman AP.

Ann Endocrinol (Paris). 2015 Apr 23. pii: S0003-4266(15)00035-9. doi: 10.1016/j.ando.2015.03.014. [Epub ahead of print] No abstract available.

PMID:
25913523
2.

Regulatory T cells in vitiligo: Implications for pathogenesis and therapeutics.

Dwivedi M, Kemp EH, Laddha NC, Mansuri MS, Weetman AP, Begum R.

Autoimmun Rev. 2015 Jan;14(1):49-56. Review.

PMID:
25308528
3.

Thyroid abnormalities.

Weetman AP.

Endocrinol Metab Clin North Am. 2014 Sep;43(3):781-90. doi: 10.1016/j.ecl.2014.05.006. Epub 2014 Jun 25.

PMID:
25169567
4.

Impact of month of birth on the development of autoimmune thyroid disease in the United Kingdom and Europe.

Hamilton A, Newby PR, Carr-Smith JD, Disanto G, Allahabadia A, Armitage M, Brix TH, Chatterjee K, Connell JM, Hegedüs L, Hunt PJ, Lazarus JH, Pearce SH, Robinson BG, Taylor JC, Vaidya B, Wass JA, Wiersinga WM, Weetman AP, Ramagopalan SV, Franklyn JA, Gough SC, Simmonds MJ.

J Clin Endocrinol Metab. 2014 Aug;99(8):E1459-65. doi: 10.1210/jc.2014-1270. Epub 2014 May 19.

PMID:
24840812
5.

Pendrin and NIS antibodies are absent in healthy individuals and are rare in autoimmune thyroid disease: evidence from a Danish twin study.

Brix TH, Hegedüs L, Weetman AP, Kemp HE.

Clin Endocrinol (Oxf). 2014 Sep;81(3):440-4. doi: 10.1111/cen.12434. Epub 2014 Mar 17.

PMID:
24612086
6.

Graves' disease following immune reconstitution or immunomodulatory treatment: should we manage it any differently?

Weetman AP.

Clin Endocrinol (Oxf). 2014 May;80(5):629-32. doi: 10.1111/cen.12427.

PMID:
24528193
7.

Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in Finnish APECED patients.

Kemp EH, Habibullah M, Kluger N, Ranki A, Sandhu HK, Krohn KJ, Weetman AP.

J Clin Endocrinol Metab. 2014 Mar;99(3):1064-71. doi: 10.1210/jc.2013-3723. Epub 2013 Jan 1.

PMID:
24423312
8.

Investigating low thyroid stimulating hormone (TSH) level.

Weetman AP.

BMJ. 2013 Nov 20;347:f6842. doi: 10.1136/bmj.f6842. No abstract available.

PMID:
24259327
9.

Acquired hypocalciuric hypercalcemia in a patient with CKD.

Kuo E, Kemp EH, Sandhu HK, Brown EM, Weetman AP, Huang CL.

Am J Kidney Dis. 2013 Dec;62(6):1151-4. doi: 10.1053/j.ajkd.2013.04.023. Epub 2013 Jun 27.

PMID:
23810542
10.

A thyroxine absorption test followed by weekly thyroxine administration: a method to assess non-adherence to treatment.

Walker JN, Shillo P, Ibbotson V, Vincent A, Karavitaki N, Weetman AP, Wass JA, Allahabadia A.

Eur J Endocrinol. 2013 May 10;168(6):913-7. doi: 10.1530/EJE-12-1035. Print 2013 Jun.

11.

Low frequency of pendrin autoantibodies detected using a radioligand binding assay in patients with autoimmune thyroid disease.

Kemp EH, Sandhu HK, Watson PF, Weetman AP.

J Clin Endocrinol Metab. 2013 Feb;98(2):E309-13. doi: 10.1210/jc.2012-3683. Epub 2013 Jan 15.

PMID:
23322815
12.

The angiotensin-converting enzyme gene insertion/deletion polymorphism in Indian patients with vitiligo: a case-control study and meta-analysis.

Patwardhan M, Pradhan V, Taylor LH, Thakkar V, Kharkar V, Khopkar U, Ghosh K, Gawkrodger DJ, Teare MD, Weetman AP, Kemp EH.

Br J Dermatol. 2013 Jun;168(6):1195-204. doi: 10.1111/bjd.12177.

PMID:
23278772
13.

The immunopathogenesis of chronic autoimmune thyroiditis one century after hashimoto.

Weetman AP.

Eur Thyroid J. 2013 Jan;1(4):243-50. doi: 10.1159/000343834. Epub 2012 Nov 2. Review.

14.

Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo.

Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, Luiten RM, Wolkerstorfer A, van der Veen JP, Hartmann A, Eichner S, Schuler G, van Geel N, Lambert J, Kemp EH, Gawkrodger DJ, Weetman AP, Taïeb A, Jouary T, Ezzedine K, Wallace MR, McCormack WT, Picardo M, Leone G, Overbeck A, Silverberg NB, Spritz RA.

Nat Genet. 2012 May 6;44(6):676-80. doi: 10.1038/ng.2272.

15.

Epitopes, avidity and IgG subclasses of tyrosine hydroxylase autoantibodies in vitiligo and alopecia areata patients.

Rahoma SF, Sandhu HK, McDonagh AJ, Gawkrodger DJ, Weetman AP, Kemp EH.

Br J Dermatol. 2012 Jul;167(1):17-28. doi: 10.1111/j.1365-2133.2012.10889.x. Epub 2012 May 14.

PMID:
22329856
16.

Thyroid disease in pregnancy in 2011: Thyroid function--effects on mother and baby unraveled.

Weetman AP.

Nat Rev Endocrinol. 2011 Dec 6;8(2):69-70. doi: 10.1038/nrendo.2011.217. Review.

PMID:
22143186
17.

Vitiligo patients from India (Mumbai) show differences in clinical, demographic and autoantibody profiles compared to patients in western countries.

Pradhan V, Patwardhan M, Thakkar V, Kharkar V, Khopkar U, Ghosh K, Weetman AP, Gawkrodger DJ, Kemp EH.

J Eur Acad Dermatol Venereol. 2013 Mar;27(3):279-86. doi: 10.1111/j.1468-3083.2011.04367.x. Epub 2011 Nov 28.

PMID:
22122088
18.

Demonstration of autoantibodies against tyrosine hydroxylase in patients with alopecia areata.

Kemp EH, Sandhu HK, Weetman AP, McDonagh AJ.

Br J Dermatol. 2011 Dec;165(6):1236-43. doi: 10.1111/j.1365-2133.2011.10597.x. Epub 2011 Nov 17.

PMID:
21895622
19.

First report of anti-calcium-sensing receptor antibodies in a patient with Sjogren's syndrome and primary hypoparathyroidism.

Harris HE, Kemp EH, Brown EM, Weetman AP, Swaminathan K.

Rheumatology (Oxford). 2011 Jun;50(6):1173-5. doi: 10.1093/rheumatology/ker128. Epub 2011 Mar 30. No abstract available.

20.

Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA.

J Invest Dermatol. 2011 Jun;131(6):1308-12. doi: 10.1038/jid.2011.12. Epub 2011 Feb 17.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk